This standard specifies the in vitro cytotoxicity test method, sample preparation and operation of nanomaterials and nanomaterials combined in medical devices.
Steps and evaluation.
This standard applies to nanomaterials and nanomaterials combined in medical devices (particles or fibers are wrapped or combined in an unreleased
In vitro cytotoxicity evaluation of the release or non-free state, including MHT assay and LDH assay with L929 as the test cell.
This standard is a supplement to GB/T 16886.5.